Company attributes
Venture Capital Firm attributes
Other attributes
Investing since 1991, EDBI is a Singapore-based global investor in select high growth technology sectors ranging from Information & Communication Technology (ICT), Emerging Technology (ET), Healthcare (HC) and other strategic industries. As a value-creating investor, EDBI assists companies to achieve their goals by leveraging their network, resources, and capital, EDBI supports companies seeking to grow in Asia and globally through Singapore.
In their investments, EDBI looks for experienced management teams with differentiated products with established product market fits or which overcomes market inefficiencies, a commercially attractive business model and a vision to compete globally.
EDBI's investments include SWAT, M-DAQ, Cityneon, Nuvation Bio, Structo, Inari, Biofourmis, ShopBack, CXA Group, Moka, Ambiq Micro and OakNorth.
Their exited investments include Livongo, LogRhythm, Moderna Therapeutics, Smaato, Knewton, Hedvig, Revance Therapeutics, Mblox, goBalto, Appcelerator, Fluidigm, Declara and Addex Therapeutics.
